Neuronal to oligodendroglial alpha-synuclein redistribution in a double transgenic model of multiple system atrophy

NeuroReport

Volumn 23, Issue 4, 2012, Pages 259-264

  Rockenstein, Edward ^a   Ubhi, Kiren ^a   Inglis, Chandra ^a   Mante, Michael ^a   Patrick, Christina ^a   Adame, Anthony ^a   Masliah, Eliezer ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

alpha synuclein; behavior; bigenic; neurodegeneration propagation

Indexed keywords

ALPHA SYNUCLEIN; MYELIN BASIC PROTEIN; PLATELET DERIVED GROWTH FACTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; MOLECULAR INTERACTION; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROGENY; PROTEIN LOCALIZATION; SHY DRAGER SYNDROME; TRANSGENIC ANIMAL;

ALPHA-SYNUCLEIN; ANIMALS; CELL COMMUNICATION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; MULTIPLE SYSTEM ATROPHY; NEURONS; OLIGODENDROGLIA;

EID: 84857156473     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3283509842     Document Type: Article

References (23)

1. Wakabayashi K, Takahashi H. Cellular pathology in multiple system atrophy. Neuropathology 2006; 26:338-345. (Pubitemid 44086838)
2. Yoshida M. Multiple system atrophy: alpha-synuclein and neuronal degeneration. Neuropathology 2007; 27:484-493. (Pubitemid 47459721)
3. Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE, et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000; 25:239-252. (Pubitemid 30316525)
4. Cabin DE, Shimazu K, Murphy D, Cole NB, GottschalkW, McIlwain KL, et al. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci 2002; 22:8797-8807. (Pubitemid 35379049)
5. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, et al. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995; 14:467-475.
6. Shults CW, Rockenstein E, Crews L, Adame A, Mante M, Larrea G, et al. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J Neurosci 2005; 25:10689-10699. (Pubitemid 41681917)
7. Rockenstein E, Mallory M, Hashimoto M, Song D, Shults CW, Lang I, et al. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J Neurosci Res 2002; 68:568-578. (Pubitemid 34575622)
8. Matsuura K, Kabuto H, Makino H, Ogawa N. Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods 1997; 73:45-48. (Pubitemid 27166123)
9. Kuczenski R, Everall IP, Crews L, Adame A, Grant I, Masliah E. Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat. Exp Neurol 2007; 207:42-51. (Pubitemid 47332481)
10. Price DL, Rockenstein E, Ubhi K, Phung V, MacLean-Lewis N, Askay D, et al. Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy -implications for excitotoxicity. PLoS One 2010; 5:e14020.
11. Ubhi K, Rockenstein E, Mante M, Inglis C, Adame A, Patrick C, et al. Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J Neurosci 2010; 30:6236-6246.
12. Beyer K. Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers. Acta Neuropathol 2006; 112:237-251. (Pubitemid 44275879)
13. Ischiropoulos H. Oxidative modifications of alpha-synuclein. Ann N Y Acad Sci 2003; 991:93-100.
14. Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, et al. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Brain 2010; 133:172-188.
15. Jin H, Ishikawa K, Tsunemi T, Ishiguro T, Amino T, Mizusawa H. Analyses of copy number and mRNA expression level of the alpha-synuclein gene in multiple system atrophy. J Med Dent Sci 2008; 55:145-153.
16. MillerDW, Johnson JM, Solano SM, Hollingsworth ZR, Standaert DG,Young AB. Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm 2005; 112:1613-1624. (Pubitemid 41598967)
17. Ubhi K, Low P, Masliah E. Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci 2011; 34:581-590.
18. Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 2009; 106:13010-13015.
19. Hansen C, Angot E, Bergstrom AL, Steiner JA, Pieri L, Paul G, et al. Alpha-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 2011; 121:715-725.
20. Lee SJ, Desplats P, Sigurdson C, Tsigelny I, Masliah E. Cell-to-cell transmission of non-prion protein aggregates. Nat Rev Neurol 2010; 6:702-706.
21. Stefanova N, Hainzer M, Stemberger S, Couillard-Despres S, Aigner L, Poewe W, et al. Striatal transplantation for multiple system atrophy -are grafts affected by alpha-synucleinopathy? Exp Neurol 2009; 219:368-371.
22. Masliah E, Rockenstein E, Adame A, Alford M, Crews L, Hashimoto M, et al. Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease. Neuron 2005; 46:857-868. (Pubitemid 40805347)
23. Masliah E, Rockenstein E, Mante M, Crews L, Spencer B, Adame A, et al. Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease. PLoS One 2011; 6:e19338.